Drug resistance is a significant challenge in treating infectious diseases. Catalysis can help develop new drugs that are less susceptible to resistance. For instance, researchers are exploring allosteric inhibitors that bind to enzymes at sites other than the active site, making it harder for pathogens to develop resistance. Moreover, catalytic processes can be used to design drugs that target multiple pathways, reducing the likelihood of resistance.
